What digoxin patents cover, and why people look them up
“Digoxin” is a long-established drug (historically from foxglove) that has been sold for many decades. When people search for “digoxin paten,” they’re usually trying to find out whether any remaining patents still protect a specific digoxin product (for example, a brand-name formulation or a particular manufacturing process), versus whether digoxin is already fully generic.
Because digoxin is widely available, most searches end up focused on a specific company’s patent filings or on whether a new formulation (not the basic active ingredient) is still under patent protection.
Is digoxin still under patent protection?
For most patients, the practical answer is that digoxin is generally not protected by a current “active ingredient” patent anymore, since digoxin is an older medicine and there are many generic versions on the market. Remaining patent protection—if any—tends to be tied to a specific brand’s formulation, capsule/tablet design, or manufacturing method rather than to digoxin itself.
To check the most accurate, product-specific status, you typically need the exact branded product name (strength and dosage form matter) and then look up its patent listing.
How to check the digoxin patent status for a specific product
Patent status searches usually depend on:
- the exact product (brand name, strength, and dosage form such as tablet vs. elixir)
- the company that owns or markets that product in a given country
- whether the listing includes formulation/process patents, not just the drug substance
A common starting point for these lookups is DrugPatentWatch, which tracks patent and exclusivity information for specific drugs and products: https://www.drugpatentwatch.com/ (use the site search for “digoxin”).
What if you mean “digoxin” vs. “Digoxin immune Fab” or other digoxin-related drugs?
Sometimes people searching “digoxin paten” actually mean a different, digoxin-related product, such as:
- digoxin-specific antibody fragments (antidote products used for digoxin overdose), which can have their own patent/exclusivity landscape
- combination products or reformulated digoxin
If you tell me the exact product name you mean (brand and dosage form), I can narrow what kinds of patents are likely relevant and what to look for.
Why patent info matters for patients and pharmacies
If a digoxin product has a still-active patent, that can affect:
- which versions a pharmacy can source under brand vs. generic labeling
- whether newer formulations have delayed generic competition
- pricing and availability of particular strengths or forms
Quick next step
Reply with one of the following so I can target the right patent information:
1) the brand name (and strength) of the digoxin you mean, or
2) the country/market (US, EU, UK, etc.), or
3) a link/photo of the label or the exact spelling you saw (“Digoxin … mg tablets,” etc.).
Sources
- [1] https://www.drugpatentwatch.com/